Mass Balance Recovery, Absorption, Metabolism, and Excretion of [14C]Acoziborole in Healthy Male Subjects after Single Microtracer Oral Dosing I – Preparation of GMP [14C]Acoziborole Drug Substance
8 October 2024
Overview
Acoziborole, an oxaborole-6 carboxamide, is being developed as an oral single dose treatment for Human African trypanosomiasis (also called "sleeping sickness"). As part of the overall development programme, the mass balance, pharmacokinetics, metabolism and excretion of acoziborole were studied in an open-label, clinical phase 1 study in six healthy male subjects. This poster describes the radiolabelling and purification of [14C]acoziborole as a GMP radiolabelled drug substance to support the human metabolism investigation.
This is part of a series of 3 posters presented at ISSX 2024: